Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.9 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |